Cargando…
Erythropoietin: New Directions for the Nervous System
New treatment strategies with erythropoietin (EPO) offer exciting opportunities to prevent the onset and progression of neurodegenerative disorders that currently lack effective therapy and can progress to devastating disability in patients. EPO and its receptor are present in multiple systems of th...
Autores principales: | Maiese, Kenneth, Chong, Zhao Zhong, Shang, Yan Chen, Wang, Shaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472733/ https://www.ncbi.nlm.nih.gov/pubmed/23109841 http://dx.doi.org/10.3390/ijms130911102 |
Ejemplares similares
-
PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection
por: Chong, Zhao Zhong, et al.
Publicado: (2012) -
Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade
por: Maiese, Kenneth, et al.
Publicado: (2012) -
Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL
por: Shang, Yan Chen, et al.
Publicado: (2012) -
Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology
por: Maiese, Kenneth, et al.
Publicado: (2009) -
Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders
por: Chong, Zhao Zhong, et al.
Publicado: (2010)